Corcept Therapeutics reported $31.43M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Ardelyx ARDX:US $ -26215000 1.59M
Aurora Cannabis Inc ACB:CN C$ -86814000 23.72M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bristol Myers Squibb BMY:US $ 3197M 9M
Canopy Growth Corp WEED:CN -114437000 194.91M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Depomed DEPO:US $ 12.09M 1.51M
Eleven Biotherapeutics EBIO:US -835000 9.8M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Johnson & Johnson JNJ:US $ 6941M 599M
Knight Therapeutics Inc GUD:CN C$ 2.34M 2.65M
Lannett LCI:US $ -23942000 3.64M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Merk MRK:US $ 5711M 652M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NOVN:VX 3.32B 176M
Novartis NVS:US 3.32B 176M
Omeros OMER:US $ -37438000 2.39M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Pfizer PFE:US $ 12099M 2104M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Tg Therapeutics TGTX:US $ -38941000 27.93M
Ziopharm Oncology ZIOP:US $ -9366000 281K